Isis Expects To Submit Its Lipid-Lowering Treatment By Early 2009
Firm has substantial interest from pharma companies looking to license the drug and expects to start an auction process “very soon,” Isis tells “The Pink Sheet” DAILY.
Firm has substantial interest from pharma companies looking to license the drug and expects to start an auction process “very soon,” Isis tells “The Pink Sheet” DAILY.